The rise of data science in public healthcare and commercial pharma: How public healthcare’s rampup of data science solutions is an opportunity for well-prepared commercial pharma organisations

The Danish healthcare system is digitalising on all fronts. With the current state of big data, artificial intelligence (AI), and machine learning, the question is not whether these tools will be used to prioritise medication, but when and how. Managers responsible for future sales need to be aware that this provides a real competitive advantage for pharmaceutical companies that are ready to integrate data science in sales, marketing, market access, and medical affairs.

This white paper outlines how to begin this transition and presents cases explaining how data science adds value to business operations.